Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTS in Chronic Hepatitis B
NCT07203118Phase 3Active, not recruiting
- Sponsor
- Xi'an Xintong Pharmaceutical Research Co., Ltd.
- Start
- Jul 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Hepenofovir in Chronic Hepatitis B (CHB), sponsored by Xi'an Xintong Pharmaceutical Research Co., Ltd.. Started Jul 2025; status: active, not recruiting.
02
Drugs
Hepenofovir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT07203118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07203118.